Anakinra
Anakinra is a pharmaceutical drug with 116 clinical trials. Currently 19 active trials ongoing. Historical success rate of 82.9%.
Success Metrics
Based on 68 completed trials
Phase Distribution
Phase Distribution
32
Early Stage
52
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.6%
68 of 90 finished
24.4%
22 ended early
19
trials recruiting
116
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Dupilumab_Metastatic NSCLC
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Clinical Trials (116)
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Dupilumab_Metastatic NSCLC
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
Randomised Evaluation of COVID-19 Therapy
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Giant Cell Arteritis and Anakinra Trial
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Anakinra in Dengue With Hyperinflammation ( AnaDen )
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 116